BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12891467)

  • 1. [Changes of fibrinolysis during labour with and without aprotinin application].
    Kühnert M; Stein W; Tekesin I; Hellmeyer L; Schmidt S
    Z Geburtshilfe Neonatol; 2003; 207(3):90-100. PubMed ID: 12891467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of thrombin-antithrombin-III complex (TAT-III) and prothrombin fragments F1 + 2 during labour with and without aprotinin administration].
    Kühnert M; Stein W; Woernle F; Tekesin I; Hellmeyer L; Schmidt S
    Z Geburtshilfe Neonatol; 2004 Jun; 208(3):98-109. PubMed ID: 15229817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fibrinolysis during and after normal childbirth.
    Mackinnon S; Walker ID; Davidson JF; Walker JJ
    Br J Haematol; 1987 Mar; 65(3):339-42. PubMed ID: 2436648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in plasma coagulation and fibrinolysis following cesarean section and relationship to deep venous thrombosis. Results of a randomized prospective comparative study with 6% hydroxyethyl starch 0.62 and low-dose heparin as thrombosis prophylaxis].
    Heilmann L; Hojnacki B; Ose C
    Z Geburtshilfe Perinatol; 1991; 195(4):176-81. PubMed ID: 1719708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.
    Cucuianu M; Knauer O; Roman S
    Thromb Haemost; 1991 Nov; 66(5):586-91. PubMed ID: 1725069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of coagulation-fibrinolysis system and cold insoluble globulin in cases of caesarean section].
    Mutoh S; Teh A; Shimoji Y; Nishi N; Saitoh M; Maki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2049-58. PubMed ID: 3878385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic activity and protein C in preeclampsia.
    Aznar J; Gilabert J; Estellés A; España F
    Thromb Haemost; 1986 Jun; 55(3):314-7. PubMed ID: 3092388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant tissue-type plasminogen activator: pharmacokinetics and effect on the hemostasis system of the human].
    Seifried E; Böck F; Tanswell P; Rijken DC; Kluft C; Heimpel H
    Klin Wochenschr; 1988; 66 Suppl 12():40-9. PubMed ID: 2450222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
    Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1995 Feb; 59(3):366-70. PubMed ID: 7532878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the activity of indicators of the fibrinolytic system on assessment of the hemostatic state].
    Savchuk OM; Hamisoniia MSh; Kizim OI; Platonova TM
    Fiziol Zh (1994); 2001; 47(3):58-63. PubMed ID: 11519252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation and fibrinolysis during normal pregnancy.
    van Wersch JW; Ubachs JM
    Eur J Clin Chem Clin Biochem; 1991 Jan; 29(1):45-50. PubMed ID: 1904779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The coagulation and fibrinolysis activities of the blood during various phases of labor].
    Schander K; Wahl W; Rehm A
    Fortschr Med; 1979 Oct; 97(38):1696-702. PubMed ID: 92443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.